Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1927458045;58046;58047 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
N2AB1763353122;53123;53124 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
N2A1670650341;50342;50343 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
N2B1020930850;30851;30852 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
Novex-11033431225;31226;31227 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
Novex-21040131426;31427;31428 chr2:178595534;178595533;178595532chr2:179460261;179460260;179460259
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Fn3-27
  • Domain position: 92
  • Structural Position: 125
  • Q(SASA): 0.7595
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1410177303 None None N 0.035 0.135 0.0401082797425 gnomAD-4.0.0 1.41807E-06 None None None None I None 0 0 None 0 0 None 0 0 1.84462E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1059 likely_benign 0.1218 benign -0.022 Destabilizing None N 0.085 neutral N 0.437553716 None None I
E/C 0.5256 ambiguous 0.6339 pathogenic -0.306 Destabilizing 0.131 N 0.181 neutral None None None None I
E/D 0.0797 likely_benign 0.0868 benign -0.337 Destabilizing None N 0.079 neutral N 0.450272297 None None I
E/F 0.5275 ambiguous 0.665 pathogenic 0.006 Stabilizing 0.041 N 0.457 neutral None None None None I
E/G 0.1199 likely_benign 0.1503 benign -0.134 Destabilizing 0.001 N 0.179 neutral N 0.476400106 None None I
E/H 0.2026 likely_benign 0.2623 benign 0.678 Stabilizing None N 0.062 neutral None None None None I
E/I 0.2544 likely_benign 0.3136 benign 0.219 Stabilizing 0.01 N 0.489 neutral None None None None I
E/K 0.0828 likely_benign 0.1027 benign 0.395 Stabilizing None N 0.035 neutral N 0.45225381 None None I
E/L 0.2666 likely_benign 0.3442 ambiguous 0.219 Stabilizing 0.004 N 0.215 neutral None None None None I
E/M 0.3072 likely_benign 0.3757 ambiguous -0.064 Destabilizing 0.131 N 0.277 neutral None None None None I
E/N 0.1064 likely_benign 0.1245 benign 0.046 Stabilizing None N 0.039 neutral None None None None I
E/P 0.5242 ambiguous 0.6214 pathogenic 0.156 Stabilizing 0.017 N 0.281 neutral None None None None I
E/Q 0.0936 likely_benign 0.1023 benign 0.077 Stabilizing None N 0.095 neutral N 0.48773182 None None I
E/R 0.1337 likely_benign 0.1734 benign 0.66 Stabilizing 0.004 N 0.145 neutral None None None None I
E/S 0.1071 likely_benign 0.123 benign -0.065 Destabilizing 0.001 N 0.104 neutral None None None None I
E/T 0.115 likely_benign 0.1348 benign 0.044 Stabilizing None N 0.079 neutral None None None None I
E/V 0.1586 likely_benign 0.19 benign 0.156 Stabilizing 0.003 N 0.179 neutral N 0.462892091 None None I
E/W 0.7411 likely_pathogenic 0.842 pathogenic 0.067 Stabilizing 0.633 D 0.173 neutral None None None None I
E/Y 0.3555 ambiguous 0.4736 ambiguous 0.23 Stabilizing 0.021 N 0.407 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.